(ORDO NEWS) — The US Special Operations Command (SOCOM), the organization that runs the US Special Forces, said in 2021 that it would soon begin clinical trials of an “anti-aging pill.” According to command officials, it can stop some of the natural degenerative effects of aging.
These efforts are not aimed at creating physical traits that do not yet exist in nature.
“We have completed preclinical safety and dosage studies pending follow-up efficacy trials in 2022,” said Navy Commander Tim Hawkins.
The tablet includes what Hawkins called a “human action small molecule” that will be converted into a nutraceutical form for both civilians and military personnel.
“These efforts are not aimed at creating physical traits that do not yet exist in nature. It is about increasing the combat readiness of our forces by improving performance, which usually deteriorates with age, he explained.
“In essence, we are working with leading industry partners and clinical research institutes to develop a nutraceutical in tablet form that is suitable for a variety of uses both civilian and military, whose end-point benefits may include improved human performance, such as increased stamina and faster recovery from injury. “.
Pharmaceutical manufacturer AstraZeneca, which is not involved in anti-aging pills (SOCOM’s partner is instead private biotech lab MetroBiotech), explains:
“Small molecule drugs have some clear advantages as therapeutic agents: most of them can be administered orally and they can pass through cell membranes to reach intracellular targets.
They can also be designed to attack biological targets in a variety of ways, and their distribution can be adapted, for example, to provide systemic effects with or without brain penetration.”
Contact us: [email protected]